AstraZeneca PLC

AstraZeneca PLCverified

AZN

Price:

$78.71

Market Cap:

$244.04B

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/On...[Read more]

Industry

Drug Manufacturers - General

IPO Date

1993-05-12

Stock Exchange

NASDAQ

Ticker

AZN

The Enterprise Value as of July 2024 (TTM) for AstraZeneca PLC (AZN) is 270.75B

According to AstraZeneca PLC’s latest financial reports and current stock price. The company's current Enterprise Value is 270.75B. This represents a change of 14.48% compared to the average of 236.51B of the last 4 quarters.

AstraZeneca PLC (AZN) Historical Enterprise Value (quarterly & annually)

How has AZN Enterprise Value performed in the past?

The mean historical Enterprise Value of AstraZeneca PLC over the last ten years is 142.38B. The current 270.75B Enterprise Value has changed 18.92% with respect to the historical average. Over the past ten years (40 quarters), AZN's Enterprise Value was at its highest in in the June 2023 quarter at 246.04B. The Enterprise Value was at its lowest in in the December 2016 quarter at 80.91B.

Quarterly (TTM)
Annual

Average

142.38B

Median

126.56B

Minimum

80.91B

Maximum

232.97B

AstraZeneca PLC (AZN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of AstraZeneca PLC Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 31.96%

Maximum Annual Enterprise Value = 232.97B

Minimum Annual Increase = -14.51%

Minimum Annual Enterprise Value = 80.91B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023231.43B-0.66%
2022232.97B22.85%
2021189.65B31.96%
2020143.72B0.79%
2019142.59B29.02%
2018110.52B6.21%
2017104.07B28.62%
201680.91B-14.51%
201594.64B1.43%
201493.30B23.62%

AstraZeneca PLC (AZN) Average Enterprise Value

How has AZN Enterprise Value performed in the past?

The current Enterprise Value of AstraZeneca PLC (AZN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

218.02B

5-year avg

188.07B

10-year avg

142.38B

AstraZeneca PLC (AZN) Enterprise Value vs. Peers

How is AZN’s Enterprise Value compared to its peers?

AstraZeneca PLC’s Enterprise Value is greater than Novartis AG (228.73B), greater than GSK plc (77.07B), greater than Roche Holding AG (250.42B), greater than Bristol-Myers Squibb Company (134.51B), greater than Sanofi (125.19B), less than Merck & Co., Inc. (347.10B), greater than Gilead Sciences, Inc. (110.87B), less than Johnson & Johnson (380.45B), less than AbbVie Inc. (360.23B), less than Eli Lilly and Company (838.69B), greater than Pfizer Inc. (238.65B), greater than Amgen Inc. (232.03B),

CompanyEnterprise ValueMarket cap
228.73B$207.64B
77.07B$80.24B
250.42B$253.34B
134.51B$86.44B
125.19B$126.84B
347.10B$318.55B
110.87B$90.40B
380.45B$372.29B
360.23B$304.29B
838.69B$814.94B
238.65B$169.83B
232.03B$177.72B

Build a custom stock screener for AstraZeneca PLC (AZN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AstraZeneca PLC using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AstraZeneca PLC (AZN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AstraZeneca PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is AstraZeneca PLC's Enterprise Value?

What is the highest Enterprise Value for AstraZeneca PLC (AZN)?

What is the 3-year average Enterprise Value for AstraZeneca PLC (AZN)?

What is the 5-year average Enterprise Value for AstraZeneca PLC (AZN)?

How does the current Enterprise Value for AstraZeneca PLC (AZN) compare to its historical average?